Long‐term efficacy and safety of a permeation‐enhanced testosterone transdermal system in hypogonadal men
@article{Arver1997LongtermEA, title={Long‐term efficacy and safety of a permeation‐enhanced testosterone transdermal system in hypogonadal men}, author={S. Arver and A. Dobs and A. Meikle and K. Caramelli and L. Rajaram and S. Sanders and N. Mazer}, journal={Clinical Endocrinology}, year={1997}, volume={47} }
An important aim in treating male hypogonadism is restoration of physiological concentrations of testosterone and its metabolites. We have assessed hormone levels, pharmacokinetics and clinical response, including safety, of a permeation‐enhanced testosterone transdermal system (TTD) in the treatment of hypogonadal men for a 12‐month period.
Topics from this paper
133 Citations
Efficacy and safety of the 2% formulation of testosterone topical solution applied to the axillae in androgen‐deficient men
- Medicine
- Clinical endocrinology
- 2011
- 55
A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function
- Medicine
- BJU international
- 2003
- 124
- PDF
Transdermal testosterone gel: pharmacokinetics, efficacy of dosing and application site in hypogonadal men
- Medicine
- BJU international
- 2004
- 27
- PDF
Randomized placebo‐controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy
- Medicine
- Clinical endocrinology
- 2001
- 101
- Highly Influenced
Long‐term substitution therapy of hypogonadal men with transscrotal testosterone over 7–10 years
- Medicine
- Clinical endocrinology
- 1999
- 122
- PDF
Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system.
- Medicine
- The Journal of urology
- 1996
- 150
Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men.
- Medicine
- The Journal of clinical endocrinology and metabolism
- 1999
- 347
- PDF
Alterations in hepatic lipase and lipoprotein subfractions with transdermal testosterone replacement therapy
- Biology, Medicine
- Clinical endocrinology
- 1999
- 34
Prostate‐specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment
- Medicine
- BJU international
- 2013
- 27
References
SHOWING 1-10 OF 31 REFERENCES
Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system.
- Medicine
- The Journal of urology
- 1996
- 150
Enhanced transdermal delivery of testosterone : a new physiological approach for androgen replacement in hypogonadal men
- Medicine
- 1992
- 48
Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.
- Medicine
- The Journal of clinical endocrinology and metabolism
- 1992
- 166
Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: influence of application site- -a clinical research center study.
- Medicine
- The Journal of clinical endocrinology and metabolism
- 1996
- 119
- PDF
Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system.
- Medicine
- Urology
- 1997
- 123
Efficacy and safety of two-year therapy with transdermal clonidine for essential hypertension.
- Medicine
- Chest
- 1988
- 18
- PDF
Adverse dermatologic reactions to transdermal drug delivery systems.
- Medicine
- Journal of the American Academy of Dermatology
- 1990
- 76
Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels.
- Medicine
- Annals of internal medicine
- 1992
- 126